NA
Naynaben Ashvinbhai Vyas
About Naynaben Ashvinbhai Vyas
Data last updated:
Naynaben Ashvinbhai Vyas is a Director at Skycraper Clinical Research Solutions Private Limited (since 2021) and Director at Tripadaclinical Solutions Private Limited (since 2023). The companies operate in Research & Development and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹88.5 Lakh; the largest is Skycraper Clinical Research Solutions Private Limited at ₹87 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Oct 2021 | 2017 | ₹87 Lakh (FY 2024) | Active | |
| Director | 02 May 2023 | 2023 | ₹1.6 Lakh (FY 2025) | Active |
Board colleagues of Naynaben Ashvinbhai Vyas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chintan Nareshchandra Sheth | 07774874 | Skycraper Clinical Research Solutions Private Limited , Tripadaclinical Solutions Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naynaben Ashvinbhai Vyas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naynaben Ashvinbhai Vyas
Naynaben Ashvinbhai Vyas currently holds 2 directorships: Skycraper Clinical Research Solutions Private Limited (Director, since 05 Oct 2021, revenue ₹87 Lakh (FY 2024)); Tripadaclinical Solutions Private Limited (Director, since 02 May 2023, revenue ₹1.6 Lakh (FY 2025)).
Naynaben Ashvinbhai Vyas was first appointed on 05 Oct 2021 as Director at Skycraper Clinical Research Solutions Private Limited. The most recent appointment on record is 02 May 2023 at Tripadaclinical Solutions Private Limited.
The 2 current companies of Naynaben Ashvinbhai Vyas that report revenue have a combined latest revenue of ₹88.5 Lakh: Skycraper Clinical Research Solutions Private Limited ₹87 Lakh (FY 2024); Tripadaclinical Solutions Private Limited ₹1.6 Lakh (FY 2025).
The current boards of Naynaben Ashvinbhai Vyas's companies include Chintan Nareshchandra Sheth (Skycraper Clinical Research Solutions Private Limited).